693 results on '"Tonstad S"'
Search Results
2. Protocol for a 20-year follow-up after a randomized controlled trial of a Mediterranean diet in pregnancy:maternal and offspring risk factors for cardiovascular disease
3. Effect of in-hospital nurse-led smoking cessation intervention for patients with atherosclerotic cardiovascular disease: a randomised pilot study
4. Smoking cessation program for patients with diabetes-success factors
5. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
6. Physical Activity and the Risk of Preterm Birth: A Systematic Review and Meta-Analysis of Epidemiological Studies
7. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
8. Physical activity and the risk of preterm birth: a systematic review and meta‐analysis of epidemiological studies
9. ESC 2021 Guideline on the prevention of cardiovascular disease in clinical practice clinical practice
10. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
11. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
12. Development of composite outcomes for individual patient data (IPD) meta-analysis on the effects of diet and lifestyle in pregnancy: a Delphi survey
13. A lower reduction in umbilical artery pulsatility in mid-pregnancy predicts higher infant blood pressure six months after birth
14. Kiwifruit decreases blood pressure and whole-blood platelet aggregation in male smokers
15. Effect of intermittent and continuous caloric restriction on Sirtuin1 concentration depends on sex and body mass index
16. Cardiovascular risk factors and body composition in adults with achondroplasia
17. Correction to: Cardiovascular risk factors and body composition in adults with achondroplasia.
18. A high-fibre bean-rich diet versus a low-carbohydrate diet for obesity
19. The effect of an increased intake of vegetables and fruit on weight loss, blood pressure and antioxidant defense in subjects with sleep related breathing disorders
20. Follow-up of diet and cardiovascular risk factors 20 years after cessation of intervention in the Oslo Diet and Antismoking Study
21. Tesaglitazar, a novel dual peroxisome proliferator-activated receptor α/γ agonist, dose-dependently improves the metabolic abnormalities associated with insulin resistance in a non-diabetic population
22. Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: results from a Norwegian study of 721 subjects
23. Choices for treatment of hyperlipidaemia
24. CHANGES IN HEALTH RELATED QUALITY OF LIFE AFTER GASTRIC BYPASS OR INTENSIVE LIFESTYLE INTERVENTION: A CONTROLLED CLINICAL STUDY: 681 accepted poster
25. Beyond Counting Macros: Are Common Fad Diets Nutritionally Adequate? An Examination of Their Micronutrient Content
26. Obesity and dyslipidaemia: T3:RS3.3
27. A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study
28. Mothersʼ negative affectivity during pregnancy and food choices for their infants
29. C-reactive protein as a predictor of disease in smokers and former smokers: a review
30. The long-term influence of orlistat on dietary intake in obese subjects with components of metabolic syndrome
31. Cigarette smoking and the metabolic syndrome
32. Identifying obese women most at risk from cardiovascular disease
33. Effects of an antiatherogenic diet during pregnancy on markers of maternal and fetal endothelial activation and inflammation: the CARRDIP study
34. Effectiveness of Colestipol Tablets vs Granules in Patients with Moderate to Severe Hypercholesterolaemia
35. Tesaglitazar as Add-On Therapy to Atorvastatin Further Improves the Lipid Profile in Subjects with Dyslipidemia: 568-P
36. Combined hormone replacement therapy improves lipids but may increase leucocytes
37. The effect of the gastrointestinal lipase inhibitor, orlistat, on serum lipids and lipoproteins in patients with primary hyperlipidaemia
38. Gestational weight gain outside the Institute of Medicine recommendations and adverse pregnancy outcomes: Analysis using individual participant data from randomised trials.
39. Gestational weight gain outside the Institute of Medicine recommendations and adverse pregnancy outcomes: Analysis using individual participant data from randomised trials
40. Impact of maternal education on response to lifestyle interventions to reduce gestational weight gain: Individual participant data meta-Analysis
41. Hormone therapy and mortality during a 14-year follow-up of 14 324 Norwegian women
42. 8-isoprostane increases scavenger receptor A and matrix metalloproteinase activity in THP-1 macrophages, resulting in long-lived foam cells
43. Undertreatment and overtreatment with statins: the Oslo Health Study 2000–2001
44. A multicentre, randomized, double-blind, placebo-controlled, 1-year study of bupropion SR for smoking cessation
45. Efficacy of long-term orlistat therapy on weight maintenance after substantial weight loss
46. Children and statins
47. Cardiovascular risk factors and testing of relatives amongst patients with familial hyperlipidaemia one decade after a clinical trial
48. Under-reporting of dietary intake by smoking and non-smoking subjects counselled for hypercholesterolaemia
49. Carotid intima-media thickness and plaque in patients with familial hypercholesterolaemia mutations and control subjects
50. Effects of intermittent versus continuous energy restriction for weight loss on diet quality and eating behavior. A randomized trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.